HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eriko Kudo Selected Research

GUT-70

2/2015Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity.
2/2013Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eriko Kudo Research Topics

Disease

6Infections
04/2020 - 02/2013
4Neoplasms (Cancer)
10/2016 - 04/2012
3Primary Effusion Lymphoma
10/2016 - 04/2012
2Human Influenza (Influenza)
04/2020 - 01/2019
2Cholangiocarcinoma
07/2016 - 01/2013
2Hypoxia (Hypoxemia)
07/2016 - 01/2016
2Ascites
03/2015 - 04/2012
1Prader-Willi Syndrome (Syndrome, Prader-Willi)
01/2020
1Cachexia
05/2019
1Virus Diseases (Viral Diseases)
01/2019
1Liver Neoplasms (Liver Cancer)
07/2016
1Neoplasm Metastasis (Metastasis)
01/2013
1Retinoblastoma (Glioblastoma, Retinal)
04/2012
1Fever (Fevers)
01/2006
1Pain (Aches)
01/2006
1Polyarteritis Nodosa (Periarteritis Nodosa)
01/2006
1Polyneuropathies (Polyneuropathy)
01/2006
1Vasculitis (Vasculitides)
01/2006
1Eosinophilia
07/2005
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
07/2005

Drug/Important Bio-Agent (IBA)

3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2016 - 03/2015
2Bevacizumab (Avastin)FDA Link
07/2016 - 03/2015
2Transcription Factors (Transcription Factor)IBA
01/2016 - 03/2015
2GUT-70IBA
02/2015 - 02/2013
1AerosolsIBA
04/2020
1Aerosolized Particles and DropletsIBA
04/2020
1Sodium-Glucose Transport ProteinsIBA
01/2020
1Glucagon-Like Peptide-1 ReceptorIBA
01/2020
1KetonesIBA
11/2019
1CarbohydratesIBA
11/2019
1Indicators and Reagents (Reagents)IBA
05/2019
1CaspasesIBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1Chloroquine (Aralen)FDA LinkGeneric
10/2016
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
07/2016
1Small Interfering RNA (siRNA)IBA
01/2016
1Oxygen (Dioxygen)IBA
01/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1Messenger RNA (mRNA)IBA
01/2016
1Interleukin-6 (Interleukin 6)IBA
03/2015
1tocilizumab (atlizumab)FDA Link
03/2015
1NF-kappa B (NF-kB)IBA
01/2013
1Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link
01/2013
1Retinoblastoma ProteinIBA
04/2012
1Poly IIBA
04/2012
1Toll-Like Receptor 3IBA
04/2012
1BerberineIBA
04/2012
1Double-Stranded RNA (RNA, Double Stranded)IBA
04/2012
1Pharmaceutical PreparationsIBA
01/2006
1Minocycline (Cyclops)FDA LinkGeneric
01/2006
1C-Reactive ProteinIBA
01/2006
1Interleukin-4 (Interleukin 4)IBA
07/2005
1Immunoglobulin G (IgG)IBA
07/2005
1Immunoglobulin E (IgE)IBA
07/2005
1Interleukin-5 (Interleukin 5)IBA
07/2005

Therapy/Procedure

1Glycemic Control
01/2020
1Therapeutics
11/2019
1Ketogenic Diet
11/2019
1Diagnostic Equipment
05/2019
1Drug Therapy (Chemotherapy)
10/2016